ABBVIE ($ABBV) posted quarterly earnings results for Q1 2026 on Wednesday, April 29th. The company reported earnings of $2.65 per share, beating estimates of $2.65 by $0.00. The company also reported revenue of $15,002,000,000, missing estimates of $15,016,292,375 by $-14,292,375.
You can see Quiver Quantitative's $ABBV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ABBVIE Insider Trading Activity
ABBVIE insiders have traded $ABBV stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by insiders over the last 6 months:
- PERRY C SIATIS (EVP, GC AND SECRETARY) has made 0 purchases and 3 sales selling 18,668 shares for an estimated $4,375,549.
- DAVID RYAN PURDUE (SVP, Controller) sold 5,230 shares for an estimated $1,221,518
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
ABBVIE Hedge Fund Activity
We have seen 1,768 institutional investors add shares of ABBVIE stock to their portfolio, and 1,849 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 37,400,173 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $8,545,565,528
- CAPITAL WORLD INVESTORS added 6,736,161 shares (+106.3%) to their portfolio in Q4 2025, for an estimated $1,539,145,426
- BLACKROCK, INC. added 5,197,454 shares (+3.6%) to their portfolio in Q4 2025, for an estimated $1,187,566,264
- CARDANO RISK MANAGEMENT B.V. removed 4,908,260 shares (-90.1%) from their portfolio in Q1 2026, for an estimated $1,062,785,537
- WELLINGTON MANAGEMENT GROUP LLP added 4,389,782 shares (+41.7%) to their portfolio in Q4 2025, for an estimated $1,003,021,289
- GEODE CAPITAL MANAGEMENT, LLC added 4,190,487 shares (+10.4%) to their portfolio in Q4 2025, for an estimated $957,484,374
- JPMORGAN CHASE & CO removed 4,141,493 shares (-7.3%) from their portfolio in Q4 2025, for an estimated $946,289,735
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
ABBVIE Government Contracts
We have seen $298,218 of award payments to $ABBV over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PROSTHETIC ORDER - IMPLANT ITEMS: $15,758
- 4568645077!NATRELLE TE SMOOTH 133S-MV-11-T: $9,109
- 4568672830!NATRELLE INSPIRA SCM 640CC BREAST IMPLAN: $9,021
- PROSTHETICS:SURGICAL IMPLANTS BREAST RECONSTRUCTION: $8,468
- 4569321051!NATRELLE INSPIRA SCF 605CC BREAST IMPLAN: $4,014
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ABBVIE Congressional Stock Trading
Members of Congress have traded $ABBV stock 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ABBV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
- REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 12/08.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.
ABBVIE Analyst Ratings
Wall Street analysts have issued reports on $ABBV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HSBC issued a "Buy" rating on 12/10/2025
To track analyst ratings and price targets for ABBVIE, check out Quiver Quantitative's $ABBV forecast page.
ABBVIE Price Targets
Multiple analysts have issued price targets for $ABBV recently. We have seen 13 analysts offer price targets for $ABBV in the last 6 months, with a median target of $260.0.
Here are some recent targets:
- David Amsellem from Piper Sandler set a target price of $294.0 on 04/23/2026
- Gary Nachman from Canaccord Genuity set a target price of $262.0 on 04/21/2026
- Vamil Divan from Guggenheim set a target price of $249.0 on 04/10/2026
- Carter Gould from Cantor Fitzgerald set a target price of $240.0 on 04/08/2026
- Trung Huynh from RBC Capital set a target price of $260.0 on 02/25/2026
- Emily Field from Barclays set a target price of $275.0 on 02/20/2026
- Terence Flynn from Morgan Stanley set a target price of $270.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
